Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-11-13
2007-11-13
Coleman, Brenda L. (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S234500, C514S252160, C544S255000, C544S278000, C544S117000
Reexamination Certificate
active
10476818
ABSTRACT:
The invention relates to pharmaceutically acceptable compounds of formula I, wherein the radicals have the significances given in the description. Compounds of formula I are useful against tumor diseases
REFERENCES:
patent: 5227387 (1993-07-01), Dreikorn et al.
patent: 6096749 (2000-08-01), Traxler et al.
patent: 0 459 611 (1991-12-01), None
patent: WO 200232872 (2002-04-01), None
Patil, Vemanna D.; Townsend, Leroy B., Journal of Heterocyclic Chemistry, 8(3), 503-5 (English) 1971.
Bold Guido
Manley Paul W
Martin-Kohler Andreas
Séquin Urs
Baron Mark
Coleman Brenda L.
Moore Susanna
Novartis AG
Novartis AG
LandOfFree
Oxazolo-and furopyrimidines and their use in medicaments... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oxazolo-and furopyrimidines and their use in medicaments..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oxazolo-and furopyrimidines and their use in medicaments... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3837409